1803 related articles for article (PubMed ID: 25392987)
21. Lifestyle interventions for chronic gout.
Moi JH; Sriranganathan MK; Edwards CJ; Buchbinder R
Cochrane Database Syst Rev; 2013 May; 2013(5):CD010039. PubMed ID: 23728699
[TBL] [Abstract][Full Text] [Related]
22. Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB.
Sharma SK; Sharma A; Kadhiravan T; Tharyan P
Evid Based Child Health; 2014 Mar; 9(1):169-294. PubMed ID: 25404581
[TBL] [Abstract][Full Text] [Related]
23. Biochemical effectiveness of allopurinol and allopurinol-probenecid in previously benzbromarone-treated gout patients.
Reinders MK; van Roon EN; Houtman PM; Brouwers JR; Jansen TL
Clin Rheumatol; 2007 Sep; 26(9):1459-65. PubMed ID: 17308859
[TBL] [Abstract][Full Text] [Related]
24. Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta-analysis.
Singh JA; Hossain A; Mudano AS; Tanjong Ghogomu E; Suarez-Almazor ME; Buchbinder R; Maxwell LJ; Tugwell P; Wells GA
Cochrane Database Syst Rev; 2017 May; 5(5):CD012657. PubMed ID: 28481462
[TBL] [Abstract][Full Text] [Related]
25. A randomised controlled trial on the efficacy and tolerability with dose escalation of allopurinol 300-600 mg/day versus benzbromarone 100-200 mg/day in patients with gout.
Reinders MK; Haagsma C; Jansen TL; van Roon EN; Delsing J; van de Laar MA; Brouwers JR
Ann Rheum Dis; 2009 Jun; 68(6):892-7. PubMed ID: 18633127
[TBL] [Abstract][Full Text] [Related]
26. Exercise for hand osteoarthritis.
Østerås N; Kjeken I; Smedslund G; Moe RH; Slatkowsky-Christensen B; Uhlig T; Hagen KB
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD010388. PubMed ID: 28141914
[TBL] [Abstract][Full Text] [Related]
27. Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease-modifying anti-rheumatic drugs: a systematic review and network meta-analysis.
Singh JA; Hossain A; Tanjong Ghogomu E; Kotb A; Christensen R; Mudano AS; Maxwell LJ; Shah NP; Tugwell P; Wells GA
Cochrane Database Syst Rev; 2016 May; 2016(5):CD012183. PubMed ID: 27175934
[TBL] [Abstract][Full Text] [Related]
28. Tramadol for osteoarthritis.
Toupin April K; Bisaillon J; Welch V; Maxwell LJ; Jüni P; Rutjes AW; Husni ME; Vincent J; El Hindi T; Wells GA; Tugwell P
Cochrane Database Syst Rev; 2019 May; 5(5):CD005522. PubMed ID: 31132298
[TBL] [Abstract][Full Text] [Related]
29. Celecoxib for rheumatoid arthritis.
Fidahic M; Jelicic Kadic A; Radic M; Puljak L
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD012095. PubMed ID: 28597983
[TBL] [Abstract][Full Text] [Related]
30. Interventions for chronic palmoplantar pustulosis.
Obeid G; Do G; Kirby L; Hughes C; Sbidian E; Le Cleach L
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD011628. PubMed ID: 31958161
[TBL] [Abstract][Full Text] [Related]
31. A benefit-risk assessment of benzbromarone in the treatment of gout. Was its withdrawal from the market in the best interest of patients?
Lee MH; Graham GG; Williams KM; Day RO
Drug Saf; 2008; 31(8):643-65. PubMed ID: 18636784
[TBL] [Abstract][Full Text] [Related]
32. Topical treatments for scalp psoriasis.
Schlager JG; Rosumeck S; Werner RN; Jacobs A; Schmitt J; Schlager C; Nast A
Cochrane Database Syst Rev; 2016 Feb; 2(2):CD009687. PubMed ID: 26915340
[TBL] [Abstract][Full Text] [Related]
33. The safety and efficacy of benzbromarone in gout in Aotearoa New Zealand.
Stamp LK; Haslett J; Frampton C; White D; Gardner D; Stebbings S; Taylor G; Grainger R; Kumar R; Kumar S; Kain T; Porter D; Corkill M; Cathro A; Metcalfe S; Wyeth J; Dalbeth N
Intern Med J; 2016 Sep; 46(9):1075-80. PubMed ID: 27391386
[TBL] [Abstract][Full Text] [Related]
34. Percutaneous vertebroplasty for osteoporotic vertebral compression fracture.
Buchbinder R; Golmohammadi K; Johnston RV; Owen RJ; Homik J; Jones A; Dhillon SS; Kallmes DF; Lambert RG
Cochrane Database Syst Rev; 2015 Apr; (4):CD006349. PubMed ID: 25923524
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of allopurinol and benzbromarone for the control of hyperuricaemia. A pathogenic approach to the treatment of primary chronic gout.
Perez-Ruiz F; Alonso-Ruiz A; Calabozo M; Herrero-Beites A; García-Erauskin G; Ruiz-Lucea E
Ann Rheum Dis; 1998 Sep; 57(9):545-9. PubMed ID: 9849314
[TBL] [Abstract][Full Text] [Related]
36. Down-titration and discontinuation strategies of tumor necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity.
van Herwaarden N; den Broeder AA; Jacobs W; van der Maas A; Bijlsma JW; van Vollenhoven RF; van den Bemt BJ
Cochrane Database Syst Rev; 2014 Sep; (9):CD010455. PubMed ID: 25264908
[TBL] [Abstract][Full Text] [Related]
37. Bisphosphonates for steroid-induced osteoporosis.
Allen CS; Yeung JH; Vandermeer B; Homik J
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD001347. PubMed ID: 27706804
[TBL] [Abstract][Full Text] [Related]
38. Chondroitin for osteoarthritis.
Singh JA; Noorbaloochi S; MacDonald R; Maxwell LJ
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD005614. PubMed ID: 25629804
[TBL] [Abstract][Full Text] [Related]
39. Safety of allopurinol compared with other urate-lowering drugs in patients with gout: a systematic review and meta-analysis.
Castrejon I; Toledano E; Rosario MP; Loza E; Pérez-Ruiz F; Carmona L
Rheumatol Int; 2015 Jul; 35(7):1127-37. PubMed ID: 25519877
[TBL] [Abstract][Full Text] [Related]
40. Methotrexate for juvenile idiopathic arthritis.
Tan J; Renton WD; Whittle SL; Takken T; Johnston RV; Tiller G; Munro J; Buchbinder R
Cochrane Database Syst Rev; 2024 Feb; 2(2):CD003129. PubMed ID: 38334147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
